Anika Therapeutics, Inc. (Public) -Develops, manufactures and commercializes therapeutic products and devices intended to repair, protect and heal bone, cartilage and soft tissues.

Advancis Pharmaceutical Corp (Public, IPO 2003) - A specialty pharmaceutical company focused on developing and marketing anti-infective therapeutics that improve efficacy and patient compliance, reduce drug resistance and decrease length of therapy.


Anesiva (Public) - Anesiva is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. We have four product candidates in various stages of development.


Aspreva Pharmaceuticals (Private) - Aspreva is a pharmaceutical company which identifies, develops and commercializes new applications for existing medicines.


AVANT Immunotherapeutics, Inc. (Public) - Engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

  BioArray Solutions, Ltd. (Private) - BioArray is a molecular diagnostics company engaged in the development and commercialization of complete assay solutions for multiplexed analysis of DNA and protein markers using a proprietary customizable bead array ("BeadChip™") format and automated assay delivery system, with available products for immunohematology, transplantation, genetic testing and immunology.
  BioMimetic, Inc. (Private) - BioMimetic Pharmaceuticals is a late-stage biopharmaceutical company focused on the development and commercialization of innovative protein-based products for the treatment of musculoskeletal and orthopedic disorders.

Cellomics, Inc. (Private) - Improving the efficiency of the drug discovery process by delivering a cell-based screening platform using flourescence-based assays.


Corixa Corp (Public) - Engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases.


Cyber-Care, Inc. (Public) -Develops and utilizes and Internet-based remote monitoring technology for the chronically ill patient.

  Diversa Corp. (Public) - A global leader in discovering and developing novel enzymes and other biologically active compounds, together known as biomolecules, from diverse environmental sources for use in agricultural, chemical processing, industrial and pharmaceutical applications.
  Dynavax Corp.- (Public IPO 2004) - Discovers and develops products to treat or prevent disease based on proprietary DNA -derived molecules and their use in modulating immune system responses.

Exelixis Pharmaceuticals, Inc. (Public) - Premier company using model organism genetics and related technologies for the identification and validation of high-quality screening targets, therapeutic proteins and biopesticides for the pharmaceutical, human diagnostic, crop protection and animal health industries.

  Nextec Applications, Inc. (Private) - Engaged in the research and manufacture of advanced materials utilizing patient core technologies centered on the placement of polymers with in a fabric or other material.
  PuriLens (Private) - Manufactures and sells a system which will automatically clean and disinfect all types of contact lenses, without chemicals, surfactants, or enzymes.
  Primera Biosystems (Private) - Primera BioSystems, formerly known as Sention, is developing novel gene expression analysis assays and instruments for use in research and diagnostic laboratories. The underlying STAR technology (Scalable Trancriptional Analysis Routine) will enable combining multiplexing (<20 genes) and real time PCR in a single assay. By increasing the throughput and costs while maintaining accuracy and quantitation, the STAR platform has the potential to provide significant benefits for researchers, health care practitioners, and patients.
  Rib-X Pharmaceuticals (Private) -Small molecule drug discovery company focused on the structure-based design of classes of anti-infective agents.
  Sagres Discovery (Private) - Pioneered and industrialized methods to rapidly identify and validate disease-causing cancer genes for use in the development of new cancer diagnostics and therapeutics.
  Small Bone Innovations, LLC. (Private) - Combining established companies with exciting, best in class products and technologies, SBI is a vertically-integrated organization with a complete product portfolio designed specifically for the small bone & joint surgeon.


[Biotechnology [Communications] [Internet / Infrastructure]